A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients
Clinical trial NCT03873532 · UNKNOWN
Trial details
- NCT number
- NCT03873532
- Sponsor
- Hutchison Medipharma Limited
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2021-06-01
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.